Fri, October 9, 2020
Thu, October 8, 2020
Wed, October 7, 2020

Nathan Weinstein Initiated (VTGN) at Strong Buy and Held Target at $180 on, Oct 8th, 2020

Nathan Weinstein of Aegis Capital, Initiated "Vistagen Therapeutics, Inc." (VTGN) at Strong Buy and Held Target at $180 on, Oct 8th, 2020.

Nathan, nor any peers, have made any analyst calls on VTGN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30